Satyam Arora: Why Are We Transfusing Kids in India?
Satyam Arora, Regional Director for South East Asia at the International Society of Blood Transfusion, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Why are we transfusing kids in India?
Delighted to share our new publication presenting national data on ‘Indications of blood transfusion in neonatal and pediatric patients in India‘.
Understanding why we transfuse is the first step toward optimizing practices, minimizing risks, and strengthening evidence-based care—especially in a population where data has been limited.
This work aims to provide clarity, spark discussion, and support better clinical decision-making across neonatal and pediatric settings.
Grateful to all collaborators who made this possible—looking forward to meaningful conversations and future collaborations in this space.”
Title: Indication of transfusion of blood components in paediatric and neonatal patients in India: Real-world multicentre data
Authors: Satyam Arora, Ruchika Goel, Ratti Ram Sharma, Sangeeta Pahuja, Nidhi Bhatnagar, Arif Vaheedu A A, Ravneet Kaur, Somnath Mukherjee, Prasun Bhattacharya, Lubna Khan, Arti Khatri, Nitu Chauhan, Abhishekh B, Romesh Jain, Gita Negi, Shamee Shastry, Yashaswi Dhiman, Ram Mohan Jaiswal, Ravi Rani, Gajendra Nath Gupta, Srinivasarao Chunchu, Nimisha Sharma, Athira Sasidharan, Vinod Kumar Panicker, Vivek Prakash
Read the Full Article on Vox Sanguinis
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 6, 2026, 16:21Anand Padmanabhan: A New Concise Nutshell Review of MGTS as an Emerging Thrombophilia
-
Apr 6, 2026, 16:17Jim Hoffman: Extracorporeal Blood Purification as an Alternative to IVIG and Transfusion in Autoimmune Disease
-
Apr 6, 2026, 16:16Ala Eddin Sagar: What Changed in the New Sepsis Guidelines 2026
-
Apr 6, 2026, 16:13Simon Senanu: Hypersegmented Neutrophils – A Classic Sign of Megaloblastic Anemia
-
Apr 6, 2026, 16:05Peter Bou Dib: Understanding von Willebrand Factor in Bleeding and Thrombotic Disorders
-
Apr 6, 2026, 15:30Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 3
-
Apr 6, 2026, 15:19Ifeanyichukwu Ifechidere: When PT and APTT Are Normal but Bleeding Persists
-
Apr 6, 2026, 14:59Michal Farkowski: Cardiooncology Also Deals with Arrhythmia
-
Apr 6, 2026, 14:08David McIntosh: What Truly Determines the Safety of Plasma Donation